1. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee.; LEADER Trial Investigators.. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-22.
2. Kanbay M, Solak Y, Siriopol D, Aslan G, Afsar B, Yazici D., Covic A. Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int Urol Nephrol. 2016;48(12):2029-2042.
3. Yazıcı D., Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol. 2017; 960:277-304.
4. Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S,Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Aug 31;377(9):839-848.
5. Sezer H, Aygün MS, Armutlu A, Acar Ö, Falay FO, Yazici D, Deyneli O, Alagöl F. Erdheim-chester disease: Case report with testes involvement and review of literature. Urol Case Rep. 2018 Feb 25;18:19-21.
6. Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire. Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group. Diabetes Ther. 2018 Aug;9(4):1615-1628. doi: 10.1007/s13300-018-0463-8.
7. Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire. Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group.
8. Diabetes Ther. 2018 Aug;9(4):1629-1645. doi: 10.1007/s13300-018-0464-7.
9. Evaluation of depression, anxiety, alexithymia, attachment, social support and somatization in functional dyspepsia. Kani, Haluk Tarik-Dural, Uzay-Kani, Ayse Sakalli-Yanartas, Omer-Kiziltas, Safak-Enc, Feruze Yilmaz-Atug, Ozlen-Deyneli, Oguzhan-Kuscu, Kemal-Imeryuz, Nese. Psychiatry and Clinical Psychopharmacology, 29:1, 45-51, DOI:10.1080/24750573.2018.1480081
10. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Sonmez A, Haymana C, Bayram F, Salman S, Dizdar OS, Gurkan E, Kargili Carlıoglu A, Barcin C, Sabuncu T, Satman I; TEMD Study Group. Diabetes Res Clin Pract. 2018 Dec;146:138-147. doi: 10.1016/j.diabres.2018.09.010.
11. Aydın H, Çelik Ö, Yazici D, Altunok Ç, Tarçın Ö, Deyneli O, Sancak S, Kıyıcı S, Aydın K, Yıldız BO; TURGEP Study Group. Prevalence and predictors of gestational diabetes mellitus: a nationwide multicentre prospective study. Diabet Med. 2019 Feb;36(2):221-227.
12. Agcaoglu O, Sengun B, Ozoran E, Bilgic C, Karabay O, Taskin OC, Yazici D, Tezelman S. Should we perform routine prophylactic central neck dissection in patients with thyroid papillary microcarcinoma? Ann Ital Chir. 2018;89:485-488.
13. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. Demir M, Deyneli O, Yılmaz Y. Turk J Gastroenterol. 2019 Mar;30(3):266-270. doi: 10.5152/tjg.2018.18559.
14. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Kıyıcı S, Güldiken S, Örük G, Ozgen Saydam B, Baldane S, Kutlutürk F, Küçükler FK, Deyneli O, Çetinarslan B, Sabuncu T, Bayram F, Satman I; TEMD Study Group. Obes Facts. 2019;12(2):167-178. doi: 10.1159/000496624.
15. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey. Roze S, Smith-Palmer J, de Portu S, Özdemir Saltik AZ, Akgül T, Deyneli O. Diabetes Technol Ther. 2019 Oct 9. doi: 10.1089/dia.2019.0198.
16. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.Sonmez A, Tasci I, Demirci I, Haymana C, Barcin C, Aydin H, Cetinkalp S, Ozturk FY, Gul K, Sabuncu T, Satman I, Bayram F; TEMD Study Group. Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22. PMID: 32088879
17. Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients. Uygur MM, Deyneli O, Yavuz DG. Growth Horm IGF Res. 2020 Dec;55:101335. doi: 10.1016/j.ghir.2020.101335. Epub 2020 Jul 15. PMID: 33190108
18. Gogas Yavuz D, Aytürk S, Çetinkalp Ş, Bayraktar F, Kulaksızoğlu M, Hekimsoy Z, et al. Clinical and demographic aspects of Paget disease of bone: A multicentric study from Turkey. Eur J Rheumatol 01 December 2020; 10.5152/eurjrheum.2020.20139
19. Sezer H, Demirkol MO, Yazici D, Kapran Y, Alagöl MF. The Clinicopathologic Characteristics of Familial and Sporadic Papillary Thyroid Carcinoma in Turkish Turk J Med Sci. 2020 Jan 30.
20. Yazıcı D, Çolakoğlu B, Sağlam B, Sezer H, Kapran Y, Aydın Ö, Demirkol MO, Alagöl F, Terzioğlu T. Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center. Eur Arch Otorhinolaryngol. 2020 Feb 12.
21. Yapici-Eser, Appadurai V. , Eren CY , Yazici D. , Chen C , Öngür D ,  Pizzagalli D , Werge T , Hall M.Association Between GLP-1 Receptor Gene Polymorphisms With Reward Learning, Anhedonia and Depression Diagnosis. Acta Neuropsychiatr 2020 Mar 26;1-8.
22. Sezer H, Yazıcı, Deyneli O., Meriçöz Ç., Esin A., Alper E..Empagliflozin Induced Ketoacidosis in a Patient Presenting With New Onset Type 2 Diabetes Mellitus Due to Indolent Pancreas Cancer. Endokrynol Pol. 2020 Mar 10.
23. Sezer H, Uren N; Yazici D. Association between BRAFV600E mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients. NORTHERN CLINICS OF ISTANBUL, 2020;321-328
24. Sezer H, Yazici D, Copur S, Dagel T, Deyneli O, Kanbay M .The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals Blood Press Monit 2021 Apr, 26 (2): 102-107.
25. Sezer H, Yazıcı D, Tezelman S, Demirkol M O , Ünal Ö F , Dilege Ş , Taşkın O Ç ,  Peker Ö, Kapran Y , Çolakoğlu B , Aygün M S, Ferhanoğlu B, Alagöl F . Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report. Indian J Pathol Microbiol Jan-Mar 2021;64(1):149-151
26. Agcaoglu O¹, Sezer A ², Makay O ³, Erdogan MF ⁴, Bayram F ⁵, Guldiken S ⁶, Raffaelli M ⁷, Sonmez YA ⁸, Lee YS ⁹, Vamvakidis K ¹⁰, Mihai R ¹¹, Duh QY ¹², Akinci B ¹³,  Alagol F ¹⁴, Almquist M ¹⁵, Barczynski M ¹⁶, Bayraktaroglu T ¹⁷,  Berber E ¹⁸, Bukey Y ¹⁹, Cakmak GK ²⁰, Canturk NZ ²¹, Canturk Z ²², Celik M ⁶, Celik O ²³, Ceyhan BO ²⁴, Cherenko S ²⁵, Clerici T ²⁶, Coombes DS ²⁷, Demircan O ²⁸, Deyneli O ¹⁴, Dionigi G ²⁹, Emre AU ²⁰, Erbil Y ²⁴, Filiz AI ³⁰, Gozu HI ³¹, Gurdal SO ³², Gurleyik G ³³, Haciyanli M ³⁴, Kebudi A ³⁰, Kim S ⁹, Koutelidakis G ³⁵, Kuru B ³⁶, Mert M ³⁷, Oruk GG ³⁸, Ozbas S ²⁴, Palazzo F ³⁹, Pandev R ⁴⁰, Riss P ⁴¹, Sabuncu T ⁴², Sahin I ⁴³, Sakman G ⁴⁴, Saygili F ⁴⁵, Senyurek YG ⁴⁶, Sleptsov I ⁴⁷, Slycke SV ⁴⁸, Teksoz S ¹⁹, Terzioglu T ⁴⁹, Tezelman S ¹, Tunca F ⁴⁶, Ugurlu MU ⁵⁰, Uludag M ⁵¹, Villar-Del-Moral J ⁵², Vriens M ⁵³, Yazici D ¹⁴Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options. Updates Surg 2021 Apr 11;1-11.
27. Eren-Yazicioglu CY¹, Kara B ², Sancak S ³, Uysal SP ⁴, Yazici D ⁵, Okuroglu N ⁶, Whitton AE ⁷, Rutherford AV ⁸, Yapici-Eser H. Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus: Exenatide Use Mediates Depressive Scores Through Increased Perceived Stress Levels J Clin Psychopharmacol 2021 Jul-Aug 01;41(4):428-435.
28. Sahin S, Sezer H, Cicek E, Yagız Ozogul Y, Yildirim M, Icli TB, Polat Korkmaz O, Durcan E, Sulu C, Somay K, Bekdemir B, Borekci S, Yazici D, Deyneli O, Ergonul O, Tabak F, Dikmen Y, Ozkaya HM, Gonen MS, Damci T, Ilkova H, Yumuk VD. The Role of Obesity in Predicting the Clinical Outcomes of COVID-19. Obes Facts. 2021 Aug 5:1-9.
29. Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question. Yazici D, Sunbul M, Yasar M, Deyneli O, Yavuz D. J Clin Ultrasound. 2021 Oct;49(8):870-877. doi: 10.1002/jcu.23030.
30. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Front Endocrinol (Lausanne). 2022 Jan 24;12:663222. doi:10.3389/fendo.2021.663222. PMID: 35140679
31. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
32. Sabuncu T, Sonmez A, Eren MA, Sahin I, Çorapçioğlu D, Üçler R, Akin Ş, Haymana C, Demirci İ, Atmaca A, Ersöz HÖ, Satman I, Bayram F; TEMD Study Group. Prim Care Diabetes. 2021 Apr;15(2):332-339. doi: 10.1016/j.pcd.2020.11.001.
33. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Front Endocrinol (Lausanne). 2022 Jan 24;12:663222. doi:10.3389/fendo.2021.663222. PMID: 35140679

1. Yurdaydin C. Before saying goodbye some recollection and some humble suggestions. J Clin Gastroenterol 2022; 56(3):195-6
2. Zeybel M, Arif M, Li X, Altay O, Yang H, Shi M, Akyildiz M, Saglam B, Gonenli MG, Yigit B, Ulukan B, Ural D, Shoaie S, Turkez H, Nielsen J, Zhang C, Uhlén M, Borén J, Mardinoglu A. Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis. Adv Sci (Weinh). 2022 Feb 7:e2104373. doi: 10.1002/advs.202104373. Epub ahead of print. PMID: 35128832.
3. Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022 Jan 12. doi: 10.1038/s41575-021-00568-5. Epub ahead of print. PMID: 35022608.
4. Leslie J, Geh D, Elsharkawy AM, Mann DA, Vacca M. Metabolic dysfunction and cancer in HCV: shared pathways and mutual interactions. J Hepatol. 2022 Feb 11:S0168-8278(22)00076-9. doi: 10.1016/j.jhep.2022.01.029. Epub ahead of print. PMID: 35157957.
5. Dundar M, Fahrioglu U, Yildiz SH, Bakir-Gungor B, Temel SG, Akin H, Artan S, Cora T, Sahin FI, Dursun A, Sezer O, Gurkan H, Erdogan M, Gunduz CNS, Bisgin A, Ozdemir O, Ulgenalp A, Percin EF, Yildirim ME, Tekes S, Bagis H, Yuce H, Duman N, Bozkurt G, Yararbas K, Yildirim MS, Arman A, Mihci E, Eraslan S, Altintas ZM, Aymelek HS, Ruhi HI, Tatar A, Ergoren MC, Cetin GO, Altunoglu U, Caglayan AO, Yuksel B, Ozkul Y, Saatci C, Kenanoglu S, Karasu N, Dundar B, Ozcelik F, Demir M, Siniksaran BS, Kulak H, Kiranatlioglu K, Baysal K, Kazimli U, Akalin H, Dundar A, Boz M, Bayram A, Subasioglu A, Colak FK, Karaduman N, Gunes MC, Kandemir N, Aynekin B, Emekli R, Sahin IO, Ozdemir SY, Onal MG, Senel AS, Poyrazoglu MH, Kisaarslan ANP, Gursoy S, Baskol M, Calis M, Demir H, Zararsiz GE, Erdogan MO, Elmas M, Solak M, Ulu MS, Thahir A, Aydin Z, Atasever U, Sag SO, Aliyeva L, Alemdar A, Dogan B, Erguzeloglu CO, Kaya N, Ozkinay F, Cogulu O, Durmaz A, Onay H, Karaca E, Durmaz B, Aykut A, Cilingir O, Aras BD, Gokalp EE, Arslan S, Temena A, Haziyeva K, Kocagil S, Bas H, Susam E, Keklikci AR, Sarac E, Kocak N, Nergiz S, Terzi YK, Dincer SA, Baskin ES, Genc GC, Bahadir O, Sanri A, Yigit S, Tozkir H, Yalcintepe S, Ozkayin N, Kiraz A, Balta B, Gonen GA, Kurt EE, Ceylan GG, Ceylan AC, Erten S, Bozdogan ST, Boga I, Yilmaz M, Silan F, Kocabey M, Koc A, Cankaya T, Bora E, Bozkaya OG, Ercal D, Ergun MA, Ergun SG, Duman YS, Beyazit SB, Uzel VH, Em S, Cevik MO, Eroz R, Demirtas M, Firat CK, Kabayegit ZM, Altan M, Mardan L, Sayar C, Tumer S, Turkgenc B, Karakoyun HK, Tunc B, Kuru S, Zamani A, Geckinli BB, Ates EA, Clark OA, Toylu A, Coskun M, Nur B, Bilge I, Bayramicli OU, Emmungil H, Komesli Z, Zeybel M, Gurakan F, Tasdemir M, Kebudi R, Karabulut HG, Tuncali T, Kutlay NY, Kahraman CY, Onder NB, Beyitler I, Kavukcu S, Tulay P, Tosun O, Tuncel G, Mocan G, Kale H, Uyguner ZO, Acar A, Altinay M, Erdem L; National Genetics Consortium Study. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium. Funct Integr Genomics. 2022 Jan 31. doi: 10.1007/s10142-021-00819-3. Epub ahead of print. PMID: 35098403.
6. Zeybel M, Altay O, Arif M, Li X, Yang H, Fredolini C, Akyildiz M, Saglam B, Gonenli MG, Ural D, Kim W, Schwenk JM, Zhang C, Shoaie S, Nielsen J, Uhlén M, Borén J, Mardinoglu A. Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients. Mol Syst Biol. 2021 Oct;17(10):e10459. doi: 10.15252/msb.202110459. PMID: 34694070; PMCID: PMC8724764.
7. Anastasiou OE, Yurdaydin C, Maasoumy B et al. A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. J Viral Hepat 2021; 28(2):410-9
8. Akarsu M, Onem S, Turan I, Adali G, Akdogan M, Akyildiz M, Aladag M, Balaban Y, Danis N, Dayangac M, Gencdal G, Gokcan H, Sertesen E, Gurakar M, Harputluoglu M, Kabacam G, Karademir S, Kiyici M, Idilman R, Karasu Z.
9. Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Turk J Gastroenterol. 2021 Sep;32(9):712-719. doi: 10.5152/tjg.2021.21608.
10. Hamid S, MR Alvares da Silva, KW Burak, T Chen, JPH Drenth, G Esmat, R Gaspar, D LaBrecque, A Lee, G Macedo, B McMahon, Q Ning, N Reau, M Sonderup, DJ van Leeuwen, D Armstrong,  Yurdaydin C. WGO Guidance for the care of patients with COVID-19 and liver disease. J Clin Gastroenterol 2021; 55:1-11
11. Gencdal G, Zeybel M, Yurdaydin C. Editorial: natural history of hepatitis delta virus-induced liver disease-less severe today but still needs attention. Aliment Pharmacol Ther 2021; 54 (4):519-20
12. Sandmann L, Yurdaydin C, Deterding K, et al. HBcrAg levels are associated with virological response to treatment with interferon in patients with hepatitis delta. Hepatol Commun 2021 in press
13. Abayli B, Abaylı C, Gencdal G. Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B.World J Gastrointest Pharmacol Ther. 2021 Mar 18;12(2):32-39. doi: 10.4292/wjgpt.v12.i2.32.
14. Makharia G, Gibson PR, Bai JC, Karakan T, Lee YY, Collins L, Muir J< Oruc N, Quigley E, Sunders D, Tuck C, Yurdaydin C, Le Mair A. World Gastroenterology Organization Global Guidelines: Diet and the gut. J Clin Gastroenterol 2022; 56(1):1-15
15. Yurdaydin C, Keskin O, Yurdcu E, et al. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. Hepatology 2021 (in press)
16. Lemppp FA, Roggenbach I, Nkongolo S, Sakin V, Schlund F, Schnitzler P, Wedemeyer H, Le Gal F, Gordien E, Yurdaydin C, Urban S. A rapid point-of-care test for the serodiagnosis of hepatitis delta virus infection. Viruses 2021; 13(12):2371
17. Bremer B, Anastasiou OE, Hardtke S, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Radu M, Idilman R, Manns MP, Cornberg M, Yurdaydin C, Wedemeyer H.  Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study. Liver Int 2021; 41(2):295-9
18. Gencdal G, Yurdaydin C. Editorial Developing new therapies for delta hepatitis: the race is on. Hepatol Commun 2021; 5(4):556-8
19. Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Çalışkan A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Gūnşar F, İdilman R, Weissenborn K, Özütemiz Ö, Yurdaydın C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021; Jun 3. doi: 10.1007/s12072-021-10207-5. Online ahead of print.
20. Attila T, Zeybel M, Yigit YE, Baran B, Ahishali E, Alper E, Aslan F, Ergonul O, Mungan Z. Upper socioeconomic status is associated with lower Helicobacter pylori infection rate among patients undergoing gastroscopy. J Infect Dev Ctries. 2020 Mar 31;14(3):298-303. doi: 10.3855/jidc.11877. PMID: 32235091.
21. Yurdaydin C, Toy M. Hepatitis delta virus infection. A large burden after all? J Infect Dis 2020; 221(10): 1573-5
22. Papatheodoridis GV, Sypsa V, Dalekos GN, Yurdaydin C, et al. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B. J Hepatol 2020; 72(6):1088-96
23. Akyıldız M, Ahıskalı E, Zeybel M, Yurdaydın C. Regional Epidemiology, Burden, and Management of Hepatitis B Virus in the Middle East Clin Liver Dis 2020; 14(6):212-4
24. Papatheodoridis GV, Dalekos GN, Idilman R, Sypsa V, Van Boemmel F, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Loglio A, Papatheodoridi M, Gatselis N, Veelken R, Lopez-Gomez M, Hansen BE, Savvidou S, Kourikou A, Vlachogiannakos J, Galanis K, Yurdaydin C, Esteban R, Janssen HLA, Berg T, Lampertico P. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. J Hepatol 2020; 73(5):1037-45
25. Wranke A, Hardtke S, Heidrich B, Dalekos G, Yalçin K, Tabak F, Gürel S, Çakaloğlu Y, Akarca US, Lammert F, Häussinger D, Müller T, Wöbse M, Manns MP, Idilman R, Cornberg M, Wedemeyer H,Yurdaydin C. Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta. J Viral Hepat 2020; 27(12):1359-68
26. Toy, M, Ahishali E, Yurdaydin C. Hepatitis delta virus epidemiology in the industrialized world. AIDS Rev 2020; 22(4):203-12
27. Wedemeyer H, Yurdaydin C, Hardtke S, et al. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomized, placebo controlled, phase 2 clinical trial. Lancet Infect Dis 2019; 19:275-86
28. Yurdaydin C, Abbas Z, Buti M, et al. Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy. J Hepatol 2019; 70:1008-15
29. Yaşar O, Karatayli E, Cengiz G, Kızılpınar M, Yurdcu E, Albayrak R, Güven A, Arslan Ö, Karahan C, Otlu B, Güdücüoğlu H, Gökahmetoğlu S, Berk E, Kirişci Ö, Sertöz R, Yurdaydin C, Bozdayi AM, Karatayli SC. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits. J Med Virol 2019; 91(12):2174-82
30. Yiğit B, Boyle M, Özler O, Erden N, Tutucu F, Hardy T, Bergmann C, Distler JHW, Adalı G, Dayangaç M, Mann DA, Zeybel M, Mann J. Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis. Gut. 2018 Oct;67(10):1907-1908. doi: 10.1136/gutjnl-2017-315668. Epub 2018 Jan 20. PMID: 29353249; PMCID: PMC6145292.
31. Zeybel M, Luli S, Sabater L, Hardy T, Oakley F, Leslie J, Page A, Moran Salvador E, Sharkey V, Tsukamoto H, Chu DCK, Singh US, Ponzoni M, Perri P, Di Paolo D, Mendivil EJ, Mann J, Mann DA. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A. Mol Ther. 2017 Jan 4;25(1):218-231. doi: 10.1016/j.ymthe.2016.10.004. Epub 2017 Jan 4. PMID: 28129116; PMCID: PMC5363305.
32. Hardy T, Zeybel M, Day CP, Dipper C, Masson S, McPherson S, Henderson E, Tiniakos D, White S, French J, Mann DA, Anstee QM, Mann J. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut. 2017 Jul;66(7):1321-1328. doi: 10.1136/gutjnl-2016-311526. Epub 2016 Mar 21. PMID: 27002005; PMCID: PMC5031527.

1. Durak Aras B, Isik S, Uskudar Teke H, Aslan A, Yavasoglu F, Gulbas Z, Demirkan F, Ozen H, Cilingir O, Inci NS, Gunden G, Bulduk T, Erzurumluoglu Gokalp E, Kocagil S, Artan S, Akay OM. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion? Mol Cytogenet. 2021 Jan 6;14(1):2.
2. Yorulmaz G, Kalkan AT, Akalin A, Alagüney ES, Gündüz E, Badak B, Aydin Buyruk B, Kebapçi MN, Efe FB, Bilgin M, Akay OM. Effect of hyperparathyroidism on coagulation: A global assessment by modified rotation thromboelastogram (ROTEM) Turk J Med Sci. 2021 May 7.
3. Gönenli MG, Komesli Z, İncir S, Yalçın Ö, Akay OM. Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity. Clin Appl Thromb Hemost. 2021 Jan-Dec.
4. Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience Ann Hematol. 2021 Jul;100(7):1667-1675.
5. Akay OM, Ozbalak M, Pehlivan M, Yildiz B, Uzay A, Yigenoglu TN, Elverdi T, Kaynar L, Ayyildiz O, Yonal Hindilerden I, Goksoy HS, Izmir Guner S, Gunes AK, Sonmez M, Kurt Yuksel M, Civriz Bozdag S, Ozkurt ZN, Toptas T, Dogu MH, Salim O, Saydam G, Yavasoglu I, Ayli M, Ozet G, Albayrak M, Birtas Atesoglu E, Toprak SK, Yildirim R, Mehtap O, Kalayoglu Besisik S, Nalcaci M, Altuntas F, Ferhanoglu B. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study . Hematol Oncol. 2021 Jun 25.
6. A 52-Year-Old Man With Progressive Weakness and Incontinence. Altintas A, Danyeli AE, Bozkurt SB, Uysal SP, Akpek S, Aygun MS, Akay OM, Kahyaoglu B, Peker S, Ure UB, Ferhanoglu B. The Neurohospitalist. 2021.
7. Ozdemir ZN, Ilhan O, Ozet G, Falay M, Yenerel M, Tuglular T, Turgut M, Guvenc B, Unal A, Ayyildiz O, Andic N, Hacihanefioglu A, Sahin F, Sencan M, Ali R, Ozsan GH, Yildirim R, Tiftik EN, Tombak A, Salim O, Kaya E, Akay OM, Okan V, Pehlivan M, Saydam G. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia. Clin Lab 2020 Sep 1;66(9).
8. Yaşar Bilge NŞ, Akay OM, Gunduz E, Bilgin M, Kasifoglu T. Circulating endothelial cells in Behçet’s disease: is there a relationship with vascular involvement? Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):105-110
9. Kalyon H, Öztürk E, Tuzlalı S, Akay OM, Ferhanoğlu B. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report. Turk J Haematol. 2019 Nov 18;36(4):296-299. Ilhan O, Ozdemir ZN, Ozet G, Falay M, Yenerel M, Tuglular T, Turgut M, Guvenc B, Unal A, Ayyıldız O, Andic N, Hacıhanefioglu A, Sahin F, Sencan M, Ali R, Ozsan GH, Yildirim R, Tiftik EN, Tombak A, Salim O, Kaya E, Akay OM, Okan V, Pehlivan M, Saydam G. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients. Transfus Apher Sci. 2019 Oct;58(5):659-662.
10. Atalar SC, Akay OM, Osmanbaşoğlu E, Masyan H, Taşkın OÇ, Ferhanoğlu B. Intravascular Large B-Cell Lymphoma Within Appendix Presenting As Acute Abdomen: A Challenging Diagnosis for Hematologists. Turk J Haematol. 2021; 38(1):89-91. Aug 4. doi: 10.4274/tjh.galenos.2020.2020.0289. Online ahead of print. Sahin DG, Akay OM, Uskudar Teke H, Andıc N, Gunduz E. Use of rotational thromboelastometry for a global screening of coagulation profile in patients of myeloproliferative neoplasms. Platelets. 2021; 32(2): 280–283
11.  Somay K, Çöpür S, Osmanbaşoğlu E, Masyan H, Arslan H,  Akay OM, Tekin S, Ferhanoğlu B. HIV ASSOCIATED NON HODGKIN LYMPHOMA: A CASE SERIES STUDY FROM TURKEY. J. Infect. Dis. (2020) 14(2):42-47. Çekdemir D, Güvenç S, Özdemirkıran F, Eser A, Toptaş T, Özkocaman V, Haydaroğlu Şahin H, Ermiş Turak E, Esen R, Cömert M, Sadri S, Aslaner M, Uncu Ulu B, Karakuş A, Selim Bapur D, Alacacıoğlu İ, Aydın D, Tekinalp A, Namdaroğlu S, Ceran F, Tarkun P, Kiper D, Çetiner M, Yenerel M, Demir AM, Yılmaz G, Terzi H, Atilla E, Malkan ÜY, Acar K, Öztürk E, Tombak A, Sunu C, Salim O, Alayvaz N, Sayan Ö, Ozan Ü, Ayer M, Gökgöz Z, Andıç N, Kızılkılıç E, Noyan F, Özen M, Pepedil Tanrıkulu F, Alanoğlu G, Özkan HA, Aslan V, Çetin G, Akyol Erikçi A, Deveci B, Ersoy Dursun F, Dermenci H, Aytan P, Gündüz M, Karakuş V, Özlü C, Demircioğlu S, Akay Yanar OM, Özatlı D, Ündar L, Tiftik EN, Türköz Sucak AG, Haznedaroğlu İ, Özcan M, Şencan M, Tombuloğlu M, Özet G, Bilgir O, Turgut B, Özcan MA, Payzın KB, Sönmez M, Ayyıldız O, Dal MS, Ertop Ş, Turgut M, Soysal T, Kaya E, Ünal A, Pehlivan M, Atagündüz I, Tuğlular Fıratlı T, Saydam G, Diz Küçükkaya R. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience. Turk J Haematol. 2019 Nov 18;36(4):230-237.
12. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O’Gorman P, Sonneveld P,Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T,Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Pomalidomide,bortezomib, and dexamethasone for patients with relapsed or refractory multiplemyeloma previously treated with lenalidomide (OPTIMISMM): a randomised,open-label, phase 3 trial. Lancet Oncol. 2019 Jun;20(6):781-794.
13. Goren Sahin D, Bayraktutar BN, Yıldız Taş A, Akay OM, Ozkaya A, Yalcin Ö, Sahin A. Can Rotational Thromboelastometry be a New Predictive Tool for RetinalVein Occlusion Development? Curr Eye Res. 2019 Apr;44(4):406-412.
14. Akay OM, Taştekin F, Çolak E. Does plateletpheresis induce a hypercoagulable state? A global assessment of donor’s hemostatic system by ROTEM. Platelets.2019;30(8):989-993.
15. Kara Kivanc B, Gönüllü E, Akay OM, Ertürk A, Bal C, Cansu DÜ, Korkmaz C. Why are male patients with Behçet’s disease prone to thrombosis? A rotational thromboelastographic analysis. Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl115):63-67.
16. Saydam G, Haznedaroglu IC, Kaynar L, Yavuz AS, Ali R, Guvenc B, Akay OM, Baslar Z, Ozbek U, Sonmez M, Aydin D, Pehlivan M, Undar B, Dagdas S, Ayyildiz O, Akin G, Dag IM, Ilhan O. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up. Hematology. 2018 Dec;23(10):771-777.
17. Akay OM. The double hazard of bleeding and thrombosis in hemostasis from a clinical point of view: A global assessment by rotational thromboelastometry (ROTEM). Clin Appl Thromb Hemost 2018;24(6):850-8.

1. Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet. 2020 Dec 5;396 (10265):1817-1828.
2. Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O’Shaughnessy J; KEYNOTE-522 Investigators. Pembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med. 2020 Feb 27;382(9):810-821.
3. Yalcin S, Gumus M, Oksuzoglu B, Ozdemir F, Evrensel T, Sarioglu AA, Sahin B, Mandel NM, Goker E; Turkey Medical Oncology Active Nutrition Platform. Nutritional Aspect of Cancer Care in Medical Oncology Patients. Clin Ther. 2019 Nov;41(11):2382-2396.
4. Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O’Shaughnessy J; KEYNOTE-522 Investigators. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med. 2022 Feb 10;386(6):556-567.
5. Uskent N, Ayla S, Molinas Mandel N, Ozkan M, Teomete M, Baloglu H, Aydıncer C, Yergok H, Dogan E, Berk B, Yazar A. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. J Oncol. 2020 Jun 29;2020:1360431.
6. Hizal M, Bilgin B, Paksoy N, Açıkgöz Ö, Sezer A, Gürbüz M, Ak N, Yücel Ş, Ayhan M, Erol C, Demirkıran A, Mandel NM, Shbair A, Gökmen İ, Başoğlu T, Paydaş S, Demiray AG, İriağaç Y, Şakalar T, Zeynelgil E, Tatlı AM, Bahçeci A, Güven DC, Caner B, Can A, Gülmez A, Karakaş Y, Yalçın B, Demirkazık A, Bilici A, Aydıner A, Yumuk PF, Şendur MAN. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2021 Jul 31.
7. Ak N, Ozkan B, Yenigun MB, Yilmazbayhan D, Toker A, Ferhatoglu F, Yasar A, Dizbay Sak S, Tanju S, Dilege S, Erus S, Bulutay P, Firat P, Molinas Mandel N, Kilickap S, Onder S, Dikmen E, Alan O, Yumuk PF, Bozkurtlar E, Lacin T, Yildizeli B, Ozturk A, Kocaturk C, Karapinar K, Urer N, Oyan B, Aydiner A, Demirkazik A, Eralp Y. The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study. J BUON. 2021 May-Jun;26(3):819-829.
8. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ.Turk J Gastroenterol. 2019 Jul;30(7):584-598.
9. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D.Melanoma Res. 2021 Oct 1;31(5):449-455.
10. Palliative care needs of the cancer patients receiving active therapy. Bağçivan G, Seven M, Paşalak Şİ, Bilmiç E, Aydın Y, Öz G, Selçukbiricik F.Support Care Cancer. 2022 Jan;30(1):749-756.
11. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. Tural D, Ölmez ÖF, Sümbül AT, Özhan N, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S, Artaç M.Int J Clin Oncol. 2021 Aug;26(8):1506-1513.
12. Experiences of breast cancer survivors during the COVID-19 pandemic: a qualitative study. Seven M, Bagcivan G, Pasalak SI, Oz G, Aydin Y, Selcukbiricik F.Support Care Cancer. 2021 Nov;29(11):6481-6493.
13. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D.Melanoma Res. 2021 Oct 1;31(5):449-455.
14. Palliative care needs of the cancer patients receiving active therapy. Bağçivan G, Seven M, Paşalak Şİ, Bilmiç E, Aydın Y, Öz G, Selçukbiricik F.Support Care Cancer. 2022 Jan;30(1):749-756.
15. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. Tural D, Ölmez ÖF, Sümbül AT, Özhan N, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S, Artaç M.Int J Clin Oncol. 2021 Aug;26(8):1506-1513.
16. Experiences of breast cancer survivors during the COVID-19 pandemic: a qualitative study. Seven M, Bagcivan G, Pasalak SI, Oz G, Aydin Y, Selcukbiricik F.Support Care Cancer. 2021 Nov;29(11):6481-6493.
17. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences. Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S.Eur Urol Focus. 2021 Sep;7(5):1061-1066.
18. Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma. Tural D, Selçukbiricik F, Ölmez ÖF, Sümbül AT, Erman M, Coşkun HŞ, Artaç M, Kılıçkap S.Int J Clin Oncol. 2022 Mar;27(3):585-591.
19. Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer. Celayir OM, Selcukbiricik F, Tanik C, Altuntas Y.Sisli Etfal Hastan Tip Bul. 2021 Jul 2;55(2):224-231.
20. The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role. Falay O, Selçukbiricik F, Tanju S, Erus S, Kapdağli M, Cesur E, Yavuz Ö, Bulutay P, Firat P, Mandel NM, Dilege Ş.Nucl Med Commun. 2021 Aug 1;42(8):922-927.
21. Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer. Selcukbiricik F, Ozdogan E, Dagel T, Tanju S, Erus S, Ertuglu LA, Kapdağlı M, Tural D, Bilici A, Dilege S, Mandel NM, Kanbay M.J Clin Pharm Ther. 2020 Apr;45(2):303-308.
22. Far From Luck’s Way: A Concurrence of Kaposi Sarcoma and Cutaneous Angiosarcoma in the Setting of Chronic Lymphocytic Leukemia. Sezgin B, Yigit YE, Tatar S, Selcukbiricik F, Durankus N, Kulac I, Atasoy P.J Cutan Aesthet Surg. 2020 Oct-Dec;13(4):344-348.

1. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee.; LEADER Trial Investigators.. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-22.
2. Kanbay M, Solak Y, Siriopol D, Aslan G, Afsar B, Yazici D., Covic A. Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int Urol Nephrol. 2016;48(12):2029-2042.
3. Yazıcı D., Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol. 2017; 960:277-304.
4. Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S,Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Aug 31;377(9):839-848.
5. Sezer H, Aygün MS, Armutlu A, Acar Ö, Falay FO, Yazici D, Deyneli O, Alagöl F. Erdheim-chester disease: Case report with testes involvement and review of literature. Urol Case Rep. 2018 Feb 25;18:19-21.
6. Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire. Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group. Diabetes Ther. 2018 Aug;9(4):1615-1628. doi: 10.1007/s13300-018-0463-8.
7. Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire. Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group.
8. Diabetes Ther. 2018 Aug;9(4):1629-1645. doi: 10.1007/s13300-018-0464-7.
9. Evaluation of depression, anxiety, alexithymia, attachment, social support and somatization in functional dyspepsia. Kani, Haluk Tarik-Dural, Uzay-Kani, Ayse Sakalli-Yanartas, Omer-Kiziltas, Safak-Enc, Feruze Yilmaz-Atug, Ozlen-Deyneli, Oguzhan-Kuscu, Kemal-Imeryuz, Nese. Psychiatry and Clinical Psychopharmacology, 29:1, 45-51, DOI:10.1080/24750573.2018.1480081
10. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Sonmez A, Haymana C, Bayram F, Salman S, Dizdar OS, Gurkan E, Kargili Carlıoglu A, Barcin C, Sabuncu T, Satman I; TEMD Study Group. Diabetes Res Clin Pract. 2018 Dec;146:138-147. doi: 10.1016/j.diabres.2018.09.010.
11. Aydın H, Çelik Ö, Yazici D, Altunok Ç, Tarçın Ö, Deyneli O, Sancak S, Kıyıcı S, Aydın K, Yıldız BO; TURGEP Study Group. Prevalence and predictors of gestational diabetes mellitus: a nationwide multicentre prospective study. Diabet Med. 2019 Feb;36(2):221-227.
12. Agcaoglu O, Sengun B, Ozoran E, Bilgic C, Karabay O, Taskin OC, Yazici D, Tezelman S. Should we perform routine prophylactic central neck dissection in patients with thyroid papillary microcarcinoma? Ann Ital Chir. 2018;89:485-488.
13. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. Demir M, Deyneli O, Yılmaz Y. Turk J Gastroenterol. 2019 Mar;30(3):266-270. doi: 10.5152/tjg.2018.18559.
14. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Kıyıcı S, Güldiken S, Örük G, Ozgen Saydam B, Baldane S, Kutlutürk F, Küçükler FK, Deyneli O, Çetinarslan B, Sabuncu T, Bayram F, Satman I; TEMD Study Group. Obes Facts. 2019;12(2):167-178. doi: 10.1159/000496624.
15. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey. Roze S, Smith-Palmer J, de Portu S, Özdemir Saltik AZ, Akgül T, Deyneli O. Diabetes Technol Ther. 2019 Oct 9. doi: 10.1089/dia.2019.0198.
16. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.Sonmez A, Tasci I, Demirci I, Haymana C, Barcin C, Aydin H, Cetinkalp S, Ozturk FY, Gul K, Sabuncu T, Satman I, Bayram F; TEMD Study Group. Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22. PMID: 32088879
17. Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients. Uygur MM, Deyneli O, Yavuz DG. Growth Horm IGF Res. 2020 Dec;55:101335. doi: 10.1016/j.ghir.2020.101335. Epub 2020 Jul 15. PMID: 33190108
18. Gogas Yavuz D, Aytürk S, Çetinkalp Ş, Bayraktar F, Kulaksızoğlu M, Hekimsoy Z, et al. Clinical and demographic aspects of Paget disease of bone: A multicentric study from Turkey. Eur J Rheumatol 01 December 2020; 10.5152/eurjrheum.2020.20139
19. Sezer H, Demirkol MO, Yazici D, Kapran Y, Alagöl MF. The Clinicopathologic Characteristics of Familial and Sporadic Papillary Thyroid Carcinoma in Turkish Turk J Med Sci. 2020 Jan 30.
20. Yazıcı D, Çolakoğlu B, Sağlam B, Sezer H, Kapran Y, Aydın Ö, Demirkol MO, Alagöl F, Terzioğlu T. Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center. Eur Arch Otorhinolaryngol. 2020 Feb 12.
21. Yapici-Eser, Appadurai V. , Eren CY , Yazici D. , Chen C , Öngür D ,  Pizzagalli D , Werge T , Hall M.Association Between GLP-1 Receptor Gene Polymorphisms With Reward Learning, Anhedonia and Depression Diagnosis. Acta Neuropsychiatr 2020 Mar 26;1-8.
22. Sezer H, Yazıcı, Deyneli O., Meriçöz Ç., Esin A., Alper E..Empagliflozin Induced Ketoacidosis in a Patient Presenting With New Onset Type 2 Diabetes Mellitus Due to Indolent Pancreas Cancer. Endokrynol Pol. 2020 Mar 10.
23. Sezer H, Uren N; Yazici D. Association between BRAFV600E mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients. NORTHERN CLINICS OF ISTANBUL, 2020;321-328
24. Sezer H, Yazici D, Copur S, Dagel T, Deyneli O, Kanbay M .The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals Blood Press Monit 2021 Apr, 26 (2): 102-107.
25. Sezer H, Yazıcı D, Tezelman S, Demirkol M O , Ünal Ö F , Dilege Ş , Taşkın O Ç ,  Peker Ö, Kapran Y , Çolakoğlu B , Aygün M S, Ferhanoğlu B, Alagöl F . Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report. Indian J Pathol Microbiol Jan-Mar 2021;64(1):149-151
26. Agcaoglu O¹, Sezer A ², Makay O ³, Erdogan MF ⁴, Bayram F ⁵, Guldiken S ⁶, Raffaelli M ⁷, Sonmez YA ⁸, Lee YS ⁹, Vamvakidis K ¹⁰, Mihai R ¹¹, Duh QY ¹², Akinci B ¹³,  Alagol F ¹⁴, Almquist M ¹⁵, Barczynski M ¹⁶, Bayraktaroglu T ¹⁷,  Berber E ¹⁸, Bukey Y ¹⁹, Cakmak GK ²⁰, Canturk NZ ²¹, Canturk Z ²², Celik M ⁶, Celik O ²³, Ceyhan BO ²⁴, Cherenko S ²⁵, Clerici T ²⁶, Coombes DS ²⁷, Demircan O ²⁸, Deyneli O ¹⁴, Dionigi G ²⁹, Emre AU ²⁰, Erbil Y ²⁴, Filiz AI ³⁰, Gozu HI ³¹, Gurdal SO ³², Gurleyik G ³³, Haciyanli M ³⁴, Kebudi A ³⁰, Kim S ⁹, Koutelidakis G ³⁵, Kuru B ³⁶, Mert M ³⁷, Oruk GG ³⁸, Ozbas S ²⁴, Palazzo F ³⁹, Pandev R ⁴⁰, Riss P ⁴¹, Sabuncu T ⁴², Sahin I ⁴³, Sakman G ⁴⁴, Saygili F ⁴⁵, Senyurek YG ⁴⁶, Sleptsov I ⁴⁷, Slycke SV ⁴⁸, Teksoz S ¹⁹, Terzioglu T ⁴⁹, Tezelman S ¹, Tunca F ⁴⁶, Ugurlu MU ⁵⁰, Uludag M ⁵¹, Villar-Del-Moral J ⁵², Vriens M ⁵³, Yazici D ¹⁴Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options. Updates Surg 2021 Apr 11;1-11.
27. Eren-Yazicioglu CY¹, Kara B ², Sancak S ³, Uysal SP ⁴, Yazici D ⁵, Okuroglu N ⁶, Whitton AE ⁷, Rutherford AV ⁸, Yapici-Eser H. Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus: Exenatide Use Mediates Depressive Scores Through Increased Perceived Stress Levels J Clin Psychopharmacol 2021 Jul-Aug 01;41(4):428-435.
28. Sahin S, Sezer H, Cicek E, Yagız Ozogul Y, Yildirim M, Icli TB, Polat Korkmaz O, Durcan E, Sulu C, Somay K, Bekdemir B, Borekci S, Yazici D, Deyneli O, Ergonul O, Tabak F, Dikmen Y, Ozkaya HM, Gonen MS, Damci T, Ilkova H, Yumuk VD. The Role of Obesity in Predicting the Clinical Outcomes of COVID-19. Obes Facts. 2021 Aug 5:1-9.
29. Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question. Yazici D, Sunbul M, Yasar M, Deyneli O, Yavuz D. J Clin Ultrasound. 2021 Oct;49(8):870-877. doi: 10.1002/jcu.23030.
30. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Front Endocrinol (Lausanne). 2022 Jan 24;12:663222. doi:10.3389/fendo.2021.663222. PMID: 35140679
31. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
32. Sabuncu T, Sonmez A, Eren MA, Sahin I, Çorapçioğlu D, Üçler R, Akin Ş, Haymana C, Demirci İ, Atmaca A, Ersöz HÖ, Satman I, Bayram F; TEMD Study Group. Prim Care Diabetes. 2021 Apr;15(2):332-339. doi: 10.1016/j.pcd.2020.11.001.

    33.Expert Panel Recommendations for Use of Standardized Glucose                         Reporting System Based on Standardized Glucometrics Plus Visual                      Ambulatory Glucose Profile (AGP) Data in Clinical Practice.  Dagdelen S,            Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Front                  Endocrinol (Lausanne). 2022 Jan 24;12:663222.                                 doi:10.3389/fendo.2021.663222. PMID:

1. Ortiz-Fernández L, Saruhan-Direskeneli G, Alibaz-Oner F, Kaymaz-Tahra S, Coit P, Kong X, Kiprianos AP, Maughan RT, Aydin SZ, Aksu K, Keser G, Kamali S, Inanc M, Springer J, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Forbess L, Langford CA, McAlear CA, Ozbalkan Z, Yavuz S, Çetin GY, Alpay-Kanitez N, Chung S, Ates A, Karaaslan Y, McKinnon-Maksimowicz K, Monach PA, Ozer HTE, Seyahi E, Fresko I, Cefle A, Seo P, Warrington KJ, Ozturk MA, Ytterberg SR, Cobankara V, Onat AM, Duzgun N, Bıcakcıgil M, Yentür SP, Lally L, Manfredi AA, Baldissera E, Erken E, Yazici A, Kısacık B, Kaşifoğlu T, Dalkilic E, Cuthbertson D, Pagnoux C, Sreih A, Reales G, Wallace C, Wren JD, Cunninghame-Graham DS, Vyse TJ, Sun Y, Chen H, Grayson PC, Tombetti E, Jiang L, Mason JC, Merkel PA, Direskeneli H, Sawalha AH. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study. Am J Hum Genet. 2021 Jan 7;108(1):84-99. doi: 10.1016/j.ajhg.2020.11.014. Epub 2020 Dec 11. PMID: 33308445; PMCID: PMC7820633.
2. Alpay-Kanıtez N, Çelik S, Bes C. Polyarthritis and its differential diagnosis. Eur J Rheumatol. 2018 Oct 1;6(4):167-173. doi: 10.5152/eurjrheum.2019.19145. PMID: 31657698; PMCID: PMC6812894.
3. Esatoglu SN, Tascilar K, Babaoğlu H, Bes C, Yurttas B, Akar S, Pehlivan O, Akleylek C, Tecer D, Seyahi E, Yuce-Inel T, Alpay-Kanitez N, Bodakci E, Tekgoz E, Colak S, Bolek EC, Koca SS, Kalyoncu U, Icacan OC, Ugurlu S, Oz HE, Hamuryudan V, Hatemi G; Turkish Society for Rheumatology COVID-19 Registry Investigators. COVID-19 Among Patients With Inflammatory Rheumatic Diseases. Front Immunol. 2021 Apr 16;12:651715. doi: 10.3389/fimmu.2021.651715. PMID: 33936073; PMCID: PMC8086428.
4. Yaşar Bilge NŞ, Kalyoncu U, Atagündüz P, Dalkılıç E, Pehlivan Y, Küçükşahin O, Bes C, Akar S, Cinar M, Emmungil H, Ersözlü D, Ateş A, Mercan R, Kimyon G, Koca SS, Gonullu E, Yazisiz V, Tekgöz E, Alpay-Kanitez N, Erden A, Kiraz S, Coskun BN, Yağız B, İlgen U, Karadağ Ö, Kilic L, Ertenli İ, Kasifoglu T. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results. Am J Ophthalmol. 2021 Aug;228:58-64. doi: 10.1016/j.ajo.2021.03.026. Epub 2021 Apr 4. PMID: 33826929.
5. Kalyoncu U, Taşcılar EK, Ertenli Aİ, Dalkılıç HE, Bes C, Küçükşahin O, Kaşifoğlu T, Alpay Kanıtez N, Emmungil H, Kimyon G, Yaşar Bilge NŞ, Akar S, Atagündüz MP, Koca SS, Ateş A, Yazısız V, Terzioğlu E, Ersözlü ED, Tufan MA, Çınar M, Mercan R, Şahin A, Erten Ş, Pehlivan Y, Yılmaz S, Keleşoğlu Dinçer AB, Gerçik Ö, Coşkun BN, Yağız B, Kaymaz Tahra S, Aksoy A, Karadağ Ö, Kılıç L, Kiraz S. Methodology of a new inflammatory arthritis registry: TReasure. Turk J Med Sci. 2018 Aug 16;48(4):856-861. doi: 10.3906/sag-1807-200. PMID: 30119164.
6. Yazici A, Kaymaz-Tahra S, Ozdemir Isik O, Kara M, Alpay-Kanitez N, Gerçik O, Omma A, Kocaer SB, Kalkan K, Yasar Bilgin NS, Aksu K, Keser G, Akar S, Onen F, Emmungil H, Kasifoglu T, Alibaz-Oner F, Direskeneli H, Cefle A. The prevalence of non-vascular pulmonary manifestations in Takayasu’s Arteritis patients: A Retrospective multi-centred Turkish cohort study. Scand J Rheumatol. 2021 Oct 13:1-5. doi: 10.1080/03009742.2021.1972535. Epub ahead of print. PMID: 34643164.
7. Gönenli MG, Kaymaz Tahra S, Kara M, Keser G, Yazıcı A, Erden A, Omma A, Gerçik Ö, Akar S, Aksu K, Kenar G, Kocaer SB, Önen F, Ersözlü D, Alibaz-Öner F, Bayramlar OF, Direskeneli H, Alpay-Kanıtez N. Pregnancy in Takayasu’s arteritis has a high risk of hypertension-related fetomaternal complications: A retrospective study of a Turkish cohort. Int J Rheum Dis. 2022 Feb;25(2):140-146. doi: 10.1111/1756-185X.14247. Epub 2021 Nov 17. PMID: 34791826.
8. Alpay-Kanitez N, Çelik S, Baltacioğlu F, Içaçan OC, Bes C, Yildizeli B. Endovascular embolisation with Amplatzer vascular plug of ruptured pulmonary artery aneurism in Behçet’s disease. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):152-153. Epub 2019 Feb 28. PMID: 30873949.
9. Girgin S, Yurumez S, Omma A, Celik S, Cemal Icacan O, Bes C, Alpay-Kanitez N. Comparison of relapse rates in Behçet’s disease with venous involvement on different doses of azathioprine therapy, a retrospective observational study. Int J Rheum Dis. 2021 Apr;24(4):562-566. doi: 10.1111/1756-185X.14075. Epub 2021 Feb 26. PMID: 33638242.
10. Alpay-Kanitez N, Pehlivan Ö, Omma A, Can-Sandikçi S, Girgin S, İçaçan OC, Çelik S, Bes C. Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis. Medicine (Baltimore). 2020 Apr;99(16):e19696. doi: 10.1097/MD.0000000000019696. PMID: 32311948; PMCID: PMC7220761.
11. Alpay-Kanitez N, Bes C, Çelik S. Reply to: Endovascular embolisation with Amplatzer vascular plug of ruptured pulmonary artery aneurism in Behçet’s disease: a commentary. Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):121. Epub 2020 Mar 25. PMID: 32242810.
12. Alibaz-Oner F, Kaymaz-Tahra S, Bayındır Ö, Yazici A, Ince B, Kalkan K, Kanıtez NA, Kocaer SB, Yasar Bilge NS, Omma A, Durak E, Ilgın C, Akar S, Kaşifoğlu T, Önen F, Emmungil H, İnanç M, Cefle A, Aksu K, Keser G, Direskeneli H. Biologic treatments in Takayasu’s Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab. Semin Arthritis Rheum. 2021 Dec;51(6):1224-1229. doi: 10.1016/j.semarthrit.2021.09.010. Epub 2021 Oct 9. PMID: 34706312.
13. Tekgoz E, Colak S, Yardimci KG, Kucuksahin O, Cinar M, Yilmaz S, Kasifoglu T, Bes C, Yagiz B, Erden A, Kilic L, Kanitez NA, Ertenli AI, Coskun BN, Ediboglu ED, Mercan R, Kiraz S, Yazisiz V, Karadag O, Atagunduz P, Kalyoncu U. Physicians’ Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database. J Clin Rheumatol. 2022 Mar 1;28(2):e318-e323. doi: 10.1097/RHU.0000000000001699. PMID: 34014053.
14. İnan YÖ, Kanıtez NA, Çelik S, Öner SY, Yılmazer B, Bes C. Demographic, clinical, and laboratory features of Turkish patients with gouty arthritis: A prospective cohort study. Eur J Rheumatol. 2019 Jan;6(1):1-6. doi: 10.5152/eurjrheum.2018.18149. PMID: 30973321; PMCID: PMC6459326.